Abstract:Background: Driven by high throughput next generation sequencing technologies and the pressing need to decipher cancer genomes, computational approaches for detecting somatic single nucleotide variants (sSNVs) have undergone dramatic improvements during the past 2 years. The recently developed tools typically compare a tumor sample directly with a matched normal sample at each variant locus in order to increase the accuracy of sSNV calling. These programs also address the detection of sSNVs at low allele frequencies, allowing for the study of tumor heterogeneity, cancer subclones, and mutation evolution in cancer development.Methods: We used whole genome sequencing (Illumina Genome Analyzer IIx platform) of a melanoma sample and matched blood, whole exome sequencing (Illumina HiSeq 2000 platform) of 18 lung tumor-normal pairs and seven lung cancer cell lines to evaluate six tools for sSNV detection: EBCall, JointSNVMix, MuTect, SomaticSniper, Strelka, and VarScan 2, with a focus on MuTect and VarScan 2, two widely used publicly available software tools. Default/suggested parameters were used to run these tools. The missense sSNVs detected in these samples were validated through PCR and direct sequencing of genomic DNA from the samples. We also simulated 10 tumor-normal pairs to explore the ability of these programs to detect low allelic-frequency sSNVs.Results: Out of the 237 sSNVs successfully validated in our cancer samples, VarScan 2 and MuTect detected the most of any tools (that is, 204 and 192, respectively). MuTect identified 11 more low-coverage validated sSNVs than VarScan 2, but missed 11 more sSNVs with alternate alleles in normal samples than VarScan 2. When examining the false calls of each tool using 169 invalidated sSNVs, we observed > 63% false calls detected in the lung cancer cell lines had alternate alleles in normal samples. Additionally, from our simulation data, VarScan 2 identified more sSNVs than other tools, while MuTect characterized most low allelic-fraction sSNVs.Conclusions: Our study explored the typical false-positive and false-negative detections that arise from the use of sSNV-calling tools. Our results suggest that despite recent progress, these tools have significant room for improvement, especially in the discrimination of low coverage/allelic-frequency sSNVs and sSNVs with alternate alleles in normal samples.

Recent Advances in Biosensors and Sequencing Technologies for the Detection of Mutations

Next Generation Sequencing Technology and Its Application in Detecting Gene Mutations

Recent advances in PCR-based methods for the enrichment of minority alleles and mutations

Application of Nanotechnology for Sensitive Detection of Low-Abundance Single-Nucleotide Variations in Genomic DNA: A Review

ENZYMATIC METHODS FOR DETECTION OF POINT MUTATIONS

Detection of ultra-rare mutations by next-generation sequencing

Advances in Genotyping Detection of Fragmented Nucleic Acids

Advances in ligase-based nucleic acid amplification technology for detecting gene mutations: a review

Nanomaterials and metal-organic frameworks for biosensing applications of mutations of the emerging viruses

Advances in DNA/RNA detection using nanotechnology.

Advances in Nanopore and Photoelectron-Based High-Throughput Sequencing Technology for Single-Molecule Sequencing

The amino acid sequences and activities of synergistic hemolysins from Staphylococcus cohnii.

Recent advances in DNA-based molecular devices and their applications in cancer diagnosis

Detecting Somatic Point Mutations in Cancer Genome Sequencing Data: a Comparison of Mutation Callers

Recent Progress in DNA Biosensors for Detecting Biomarkers in Living Cells

Single molecule targeted sequencing for cancer gene mutation detection

Advancements in Biosensors for Point-of-Care Testing of Nucleic Acid

Advances in quantum dot-based biosensors for DNA-modifying enzymes assay

Label-free and High-Sensitive Detection for Genetic Point Mutation Based on Hyperspectral Interferometry

Perspectives and Challenges of Emerging Single-Molecule DNA Sequencing Technologies.

Recent Advances in Biosensors for Nucleic Acid and Exosome Detection